News Coverage 10.20.20 Share on Twitter Share on Facebook Share on LinkedIn The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Related Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration Announcement, Our Impact PICI Network Researchers at #AACR23